Cargando…
Fast-track drug approval in inflammatory bowel diseases
Fast-track drug designation of safe regimens represents an emerging method of development and approval of new medications targeting debilitating diseases including inflammatory bowel diseases (IBD). The goal of accelerated drug approval pathways is to shorten the time between application and approva...
Autores principales: | Katsanos, Konstantinos H., Koutroumpakis, Efstratios, Giagkou, Eftychia, Malakos, Zikos, Almpani, Eleni, Skamnelos, Alexandros, Christodoulou, Dimitrios K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049549/ https://www.ncbi.nlm.nih.gov/pubmed/27708508 http://dx.doi.org/10.20524/aog.2016.0051 |
Ejemplares similares
-
Dermal Lesions and Skin Cancer in Patients with Inflammatory Bowel Disease Receiving Immunosuppressive Therapy
por: Giagkou, Eftychia, et al.
Publicado: (2018) -
CD4 count remission hypothesis in patients with inflammatory bowel disease and human immunodeficiency virus infection: a systematic review of the literature
por: Skamnelos, Alexandros, et al.
Publicado: (2015) -
Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Fousekis, Fotios S., et al.
Publicado: (2019) -
Serum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs
por: Roda, Giulia, et al.
Publicado: (2019) -
Biomarker Development in Chronic Inflammatory Diseases
por: Katsanos, Aristeidis H., et al.
Publicado: (2017)